Want to join the conversation?
$AGN said it has received a Positive Opinion from the Swedish Medical Products Agency for BELKYRA. BELKYRA will be the first prescription medicine to be licensed in Europe for the treatment of moderate to severe convexity or fullness associated with submental fat (SF) in adults when the presence of SF has a psychological impact for the patients.
Looks like $BAC is regaining its lost reputation after the 2008 financial crisis. I hope the stock will flourish under Trump.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!